Therapy Areas: Hereditary Disorders
29 July 2021 - - US-based Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) will initiate a Phase 3 development program for the new once-daily investigational triple combination of VX-121/tezacaftor/VX-...
29 July 2021 - - US-based clinical-stage messenger RNA medicines company Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) has received approval from the UK Health Research Authority to initiate a Ph...
19 July 2021 - - US-based biotechnology company Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) has begun a Phase 2 proof-of-concept study in acute pain following bunionectomy surgery with the selecti...
25 June 2021 - - UK-based biotechnology company Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) has reached a new portfolio agreement with the Italian Medicines Agency, AIFA, for the reimbursement of ...
21 June 2021 - Biotechnology company Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) reported on Friday the receipt of Health Canada's marketing authorisation for the prescription medicine TRI...
28 May 2021 - - US-based gene editing company Metagenomi has received an award from the Cystic Fibrosis Foundation to identify and evaluate novel gene editing systems for the development of therapeuti...
Related Headlines